A randomized, double-blind, placebo-controlled, phase 2 study of S-033188 in otherwise healthy adult patients with influenza

Trial Profile

A randomized, double-blind, placebo-controlled, phase 2 study of S-033188 in otherwise healthy adult patients with influenza

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2017

At a glance

  • Drugs S 033188 (Primary)
  • Indications Influenza A virus infections; Influenza B virus infections
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Shionogi
  • Most Recent Events

    • 25 Apr 2017 Primary endpoint (Time to alleviation of seven influenza symptoms (TTAS)) has been met, according to the results presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases
    • 25 Apr 2017 Results presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases
    • 24 Apr 2017 Results published in a Shionogi media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top